ArticleFrontiers in oncology2021

OXCT1 Enhances Gemcitabine Resistance Through NF-κB Pathway in Pancreatic Ductal Adenocarcinoma.

Jinsheng Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.